Healthcare Workers Had Allergic Reactions after Taking COVID-19 Vaccine from Pfizer

Healthcare workers had allergic reactions after taking the COVID-19 vaccine from Pfizer

Since receiving the coronavirus vaccine from Pfizer Inc and BioNTech, an Alaskan health worker had an extreme allergic reaction but is now stable, public health officials said on Wednesday.

The person’s adverse reaction minutes after taking the Pfizer shot on Tuesday, was similar to two cases in Britain recorded last week.

Britain’s medical regulator also said that the Pfizer-BioNTech COVID-19 vaccine should not be given to someone with a history of anaphylaxis or serious allergic reactions to a drug or food.

But for the U.S. The Administration of Food and Drugs has said that the vaccine should be safe for most Americans with allergies.

It said that only persons who have had serious allergic reactions to vaccinations or components in this unique vaccine before could stop getting the injection.

Lindy Jones, the head of the emergency department in the capital of Juneau, where the woman was treated, told reporters at a simulated conference that the Alaskan patient has no history of allergic reactions.

Jones said the symptoms improved in the middle-aged patient after injecting epinephrine with allergy medication. The patient was still being treated on Wednesday at Juneau’s Bartlett Regional Hospital.

Pfizer said the vaccine came with a strong alert that in the event of anaphylaxis, adequate medical care and monitoring should still be readily accessible, although it will, if possible, amend the vaccine labeling terminology.

In the United States, the administration of the vaccine started Monday, following last week’s emergency-use permit. For healthcare staff and nursing home patients, early doses were set aside.

+ posts

Nasiru Eneji Abdulrasheed Is a Forsige breaking news reporter and editor, covering Europe, Africa, and the U.S. from Abuja.

More Stories

Europe is Now The Epicenter of Coronavirus With More Than 140,000 Cases Daily

Nasiru Eneji Abdulrasheed

China Gives Sinopharm COVID-19 Vaccine for Use, Chasing More Than 90% Success Rate

Nasiru Eneji Abdulrasheed

Global Coronavirus Deaths Reach 900,000 as Cases Grow in India


“Africa Don’t Have to Get Into a Vaccine Moral Crisis” CDC Chief Says

Nasiru Eneji Abdulrasheed

Global Coronavirus Cases Passed 22 million

Nasiru Eneji Abdulrasheed

U.S. Daily Cases of Coronavirus Surpass 129,000, as the Third Outbreak Sweeps the Country


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Homepage for World Breaking News

Forsige uses cookies to improve your experience. Are you OK with this? You can opt-out if you wish. Accept Read More

Privacy & Cookies Policy